ArticleScientific reports2018

Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.

Derek P Logsdon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.